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Rizzo M, Evangelista M, Mariani L, Simili M, Rainaldi G,
Pitto L. Immortalized mouse embryo fibroblasts are resistant to
miR-290-induced senescence regardless of p53 status. Physiol
Genomics 43: 1153–1159, 2011. First published August 16, 2011;
doi:10.1152/physiolgenomics.00064.2011.—The prosenescence role
of miR-290 and nocodazole has been documented in primary mouse
embryo fibroblasts (MEF), while it is not clear whether immortal
murine fibroblasts are still responsive to these senescence inducing
stimuli. To establish this point, immortal murine fibroblasts with
functional (NIH3T3) or nonfunctional p53 (I-MEF) and low levels of
miR-290 were tested for their capability to undergo senescence after
exposure to either nocodazole or miR-290. Our results clearly indicate
that nocodazole induces senescence only in NIH3T3 cells with a
functional p53 but not in I-MEF lacking a functional p53. miR-290
overexpression is unable to address any of the tested immortalized
clones toward senescence, regardless of the p53 status, suggesting that
the prosenescence role of miR-290 is specific for primary but not for
immortal murine fibroblasts. Moreover our findings suggest that the
mere downregulation of a potential tumor suppressor miRNA in a
given cell type does not necessarily imply that it behaves as a tumor
suppressor.
microRNA-290; nocodazole
THE LIFE SPAN of mouse embryo fibroblasts (MEF) under the
6T3 propagation regimen is very short: after 4–5 passages it is
exhausted and an appreciable fraction of cells become senes-
cent acquiring a flat morphology and a positivity to pH 6.0
senescence-associated -galactosidase (SA--gal) cells stain-
ing (2, 8). In line with the progressive increase of SA--gal
cells is the enhanced expression of p19ARF and p16, both
encoded by the INK4a/ARF locus (14). p19ARF activates the
tumor suppressor p53 by inhibiting MDM2 thus preventing
p53 ubiquitination (16), while p16 inhibits cyclin-dependent
protein kinases, thereby activating retinoblastoma, which
blocks E2F1 and the cell cycle (13). p21, another cyclin-
dependent kinase inhibitor under p53 control (5), also in-
creases during senescence (9). We have shown that MEF
population in culture is characterized not only by the in-
crease of p19ARF, p16, and p21 but also by a progressive
accumulation of cells with 4C DNA content (9). These cells
are probably G1 tetraploid cells, which, in the presence of
wild-type p53, do not progress into the cell cycle and
undergo senescence (9). It is known that a prolonged tetra-
ploid G1 arrest addresses p53-positive cells toward senes-
cence (15), in accordance with the concept that senescence
is a tumor suppressor mechanism by which cells potentially
prone to transformation are eliminated (2). The analysis of
microRNA (miRNA or miR) expression levels in senescent
MEF revealed that the entire miR-290 –295 cluster increases
during senescence, reaching the highest expression when the
shift from 2C to 4C is fully accomplished (9). The prose-
nescence role of miR-290 was verified by overexpressing
this miRNA in early passage MEF (P-MEF), where it
induced premature senescence. In accordance with these
findings we observed increased miR-290 expression after
prolonged treatment of MEF with nocodazole (NCZ), which
induced both tetraploid G1 and SA--gal cells (9).
It is known that MEF, during the immortalization process,
escape senescence by functionally eliminating some of the
above-mentioned tumor suppressor genes. In MEF, exten-
sively used as a model system to study senescence and
immortalization, the functional silencing of either the
INK4a/ARF locus (10) or p53 (3) appears to be necessary
steps to bypass senescence.
As the prosenescence role of miR-290 and NCZ was dem-
onstrated in primary MEF, with functional cell cycle check
points (INK4a/ARF locus and p53) (9), it was interesting to ask
whether immortalized MEF are still responsive to these stim-
uli. To verify this point, clones from immortalized MEF
(immortalized clones, I-clones) as well as NIH3T3 were tested
for their capability to undergo senescence after either miR-290
transfection or NCZ treatment.
MATERIALS AND METHODS
Reagents. We used the following: mature miR-290 and double-
stranded oligonucleotide negative control (miR-NC) (GenePharma,
Shanghai, China); Gene Silencer (Gene Therapy Systems, San Diego,
CA); oligo-FITC (IFC, Pisa, Italy); miRNeasy mini kit, QuantiTect
Reverse Transcription Kit, miScript Reverse Transcription Kit, mi-
Script SYBR Green PCR Kit (QIAGEN, Milano, Italy); Dulbecco’s
modified eagle medium-high glucose (DMEM-HG), Optimem, fetal
bovine serum (FBS) (Invitrogen, Carlsbad, CA); LightCycler 480
Probes Master, Universal Probe Library LNA Probes; LightCycler
480 SYBR Green I Master (Roche Diagnostic, Mannheim, Germany);
X-Gal (5-bromo-4-chloro-3-indolylb-D-galactoside); propidium io-
dide, crystal violet, NCZ; anti--tubulin (Sigma-Aldrich, St. Louis,
MO); anti-p16, anti-p21 (Santa Cruz Biotechnology); ECL, Hy-
bond-C extra membranes (Amersham); anti-p19ARF (ab Cam); Nut-
lin-3 (a kind gift by Dr. G. Del Sal).
Cells and culture conditions. MEF were isolated from 13.5-day
mouse embryos, expanded, and then replated every 3 days (9).
Colonies isolated from postsenescence MEF were expanded to obtain
clonal populations (named I-clones) to be used for the analyses. MEF
and derived clones were grown in DMEM-HG-10% FBS. NIH3T3
were grown in Dulbecco’s modified Eagle’s medium-low glucose
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(DMEM-LG)-10% FBS. All cell types were incubated at 37°C in a
humidified atmosphere containing 6% CO2.
Cell proliferation. Cell proliferation was measured as number of
cell doublings per passage (CD)  ln(Nf/Ni)/ln2, where Nf is the final
number of collected cells (day 3) and Ni the initial number of seeded
cells (day 0).
Quantification of miRNAs and genes with real-time PCR. Total
RNA was extracted from 1  106 cells using the miRNeasy mini kit
(Qiagen) following the manufacturer’s recommendations. To quantify
p19ARF, p16, and p21 transcripts, 1 g of total RNA was reverse
transcribed using QuantiTect Reverse Transcription Kit (Qiagen).
Real-time PCR (qRT-PCR) was carried out with LightCycler 480
(Roche) using LightCycler 480 SYBER Green I Master (Roche).
Mature miR-290, miR-291–3p, miR-292–3p, and miR-295 were
quantified using the miScript System: 1 g of total RNA was retro-
transcribed with miScript Reverse Transcription Kit (Qiagen) and
qRT-PCR was carried out using miScript SYBR Green PCR Kit
(Qiagen). All reactions were performed in triplicate. Relative quanti-
fication of genes and miRNAs expression was calculated with the fit
point method. Transcript values were normalized with those obtained
from the amplification of the internal controls (GAPDH for transcripts
and U6 for miRNAs). The expression values of the miR-290–295
cluster were converted into a heat map using JcolorGrid (6). The
following oligonucleotides were used: p19ARF, forward (F) (5=-
CATGGGTCGCAGGTTCTTG-3=) and reverse (R) (5=-GCTCGCTGTC-
CTGGGTCTC-3=); p16, F (5=-CGACGGGCATAGCTTCAG-3=) and R
(5=-GCTCTGCTCTTGGGATTGG-3=); p21, F (5=-TCCACAGC-
GATATCCAGACA-3=) and R (5=-GGACATCACCAGGATTGGAC-3=);
p53, F (5=-ATGCCCATGCTACAGAGGAG-3=) and R (5=-AGACTGGC-
CCTTCTTGGTCT-3=); GAPDH, F (5=-GCCTTCCGTGTTCCTACCC-
3=), R (5=-TGCCTGCTTCACCACCTTC-3=); miR-290, F (5=-ACT-
CAAACTATGGGGGCACTTT-3=); miR-291–3p, F (5=-AAAGTGCTTC-
CACTTTGTGTGC-3=); miR-291–3p, F (5=-AAAGTGCTTCCAC-
TTTGTG TGC-3=); miR-292–3p, F (5=-AAAGTGCCGCCAGGTTTT-
GAGTGT-3=); miR-295, F (5=-AAAGTGCTactacttttgagtct-3=); U6, F (5=-
CGCAAGGATGACACGCAAATTC-3=).
Western blot analysis. Equivalent amounts of proteins were re-
solved on 12% SDS-PAGE gels and transferred to Hybond-C extra
membranes by electro-blotting. The resulting blots were blocked with
5% nonfat dry milk solution. Anti--tubulin (1:1,000), anti-p19ARF
(1:2,000), anti-p16 (1:200) and anti-p21 (1:1,000) were used. Incuba-
tion was performed overnight at 4°C, and bands were revealed after
incubation with the recommended secondary antibody coupled to
peroxidase using ECL. Scanned images were quantified using Scion
Image software and normalized to -tubulin.
SA -gal activity. In brief, 2  104 cells were seeded in 30 mm
diameter dishes, and 24 h later dishes were washed once with PBS and
fixed for 3–5 min at room temperature in PBS containing 2% form-
aldehyde-0.2% glutaraldehyde. Cells were then washed three times with
PBS and incubated at 37°C with fresh SA -gal staining solution
containing 1 mg/ml 5-bromo-4-chloro-3-indolyl P3-D-galactoside (X-
Gal) (stock  20 mg/ml in DMSO), 5 mM potassium ferrocyanide, 5
mM potassium ferricyanide, 2 mM MgCl2 in PBS pH 6.0. After 24 h
cells were washed in PBS and stained with 20 g/ml Hoechst 33342 for
10 min. Dishes were scored with a Leica ILDM inverted microscope to
count SA--gal cells and Hoechst-positive nuclei. The ratio SA--gal
cells/Hoechst-positive nuclei of 10 consecutive fields (750 nuclei) was
used to determine the frequency of the event.
Cell cycle. Samples of 5 105 of cells under test were fixed with 95%
ethanol, stained with 50 g/ml propidium iodide, and incubated over-
night at 4°C, and cell cycle was analyzed on a FACScalibur cytofluo-
rimeter.
Colony forming ability. Cells under test were seeded at a density
of 1  103 per 100 mm dish, and 10 days later dishes were stained
with 2% crystal violet. The colony-forming ability was calculated
by the ratio (number of colonies formed/number of seeded cells).
miR-290 transfection. Cells under test were seeded at cell density of
1.0  105 per 30 mm diameter dish. After 24 h cells were transfected
with either miR-290 or a double-stranded oligonucleotide, named
miR-NC. Briefly, 15 l Optimem and 25 l transfection buffer plus 80
nM miRNA were mixed with a solution of Gene Silencer (5 l) plus
Optimem (25 l). After 15 min incubation, Optimem was added up to
800 l. Then, the transfection mixture was added to 30 mm diameter
dishes seeded with 1.5 105 cells 24 h earlier. After 6 h the medium was
replaced with complete DMEM. Cells were collected at 48 h posttrans-
fection and used for the detection of SA--gal cells.
NCZ treatment. I-clones and NIH3T3 fibroblasts were seeded at
cell density of 5  105 per 100 mm diameter dish. After 24 h culture
medium was replaced with medium containing NCZ (50 ng/ml), and
16 h later cells were collected and used to detect cell cycle, SA--gal
cells and miR-290–295 cluster expression.
Nutlin-3 treatment. P-MEF, immortalized MEF (I-MEF), I-5 clone,
and NIH3T3 fibroblasts were seeded at cell density of 3 105 per 100
mm diameter dish. After overnight incubation, culture medium was
replaced with medium containing 10 M nutlin-3, and 24 h later cells
were collected and used to detect p21 expression.
Fig. 1. Characterization of mouse embryo fibroblasts (MEF) under 6T3 propagation regimen. A: proliferation curve of MEF expressed as cell doublings per
passage. Primary MEF (P-MEF), senescent MEF (S-MEF), and immortalized MEF (I-MEF) were distinguished on the basis of cell doublings. B: expression of
p19ARF, p16, and p21 mRNAs in P-MEF, S-MEF, and I-MEF normalized to that of MEF at passage 0; each bar represents the mean  SD of 3 biological
replicates.
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Statistical analysis. Data were analyzed using GraphPad Prism
(GraphPad Software, San Diego, CA). Comparisons were evaluated
by unpaired t-test. Values of P 	 0.05 (*), P 	 0.01 (**), and P 	
0.001 (***) were considered statistically significant.
RESULTS AND DISCUSSION
It is known that MEF escape senescence and acquire a
proliferative phenotype after continuous propagation in culture
Fig. 2. Molecular and cellular characterization of I-clones. A: expression level of p19ARF, p16, p53, and p21 in I-clones (I-1, 2, 3, 5) normalized to that of P-MEF;
each bar represents the mean  SD of 3 biological replicates. B: Western blot of p19ARF, p16, and p21 in I-clones and I-MEF normalized to that of P-MEF;
the value reported under each lane represents the average of 2 experiments. C: expression of p21 in P-MEF, I-MEF, I-5, and NIH3T3 after 24 h treatment with
10 M nutlin-3; each bar represents the mean  SD of 3 biological replicates. D: Western blot of p21 in P-MEF, I-MEF, I-5, and NIH3T3 after 24 h treatment
with 10 M nutlin-3; the value reported under each lane represents the average of 2 experiments. E: DNA content profiles determined after propidium iodide
(PI) staining of P-MEF and I-clones. F: colony forming ability of P-MEF, S-MEF, and I-clones; each bar represents the mean  SD of 3 biological replicates.
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(3). In our case, the onset of proliferating MEF occurred at
passage 6 and thereafter I-MEF fully replaced senescent MEF
(S-MEF) (Fig. 1A). As the functional loss of either the INK4a/
ARF locus and/or p53 (3, 18) is often associated with the
escape from senescence the levels of p16 and p19ARF as well
as that of p21 (under p53 control) transcripts were deter-
mined in P-MEF, S-MEF, and I-MEF. As expected the level
of p19ARF, p16, and p21 mRNAs was greater in S-MEF
than in P-MEF. An interesting change is observed in I-MEF
where the expression of p21 dramatically diminished, while
p19ARF and p16 were still highly transcribed (Fig. 1B).
Collectively, these results suggest that I-MEF have a func-
tional loss of p53, while the INK4a/ARF locus remains
expressed. Analogously all the clones isolated from I-MEF
population (named I-1, 2, 3, 5), showed upregulation of both
p19ARF and p16 and downregulation of p21, while p53
mRNA level remained constant (Fig. 2A). The protein levels
of p19ARF, p16, and p21 were in accordance with the tran-
script levels (Fig. 2B). To test whether the marked downregu-
lation of p21 was caused by a functional inactivation of p53,
P-MEF, I-MEF, I-5, as well as NIH3T3, were treated with
nutlin-3. This is a small molecule antagonist of MDM2 that
induces p53 and consequently p21 without causing DNA
damage (4). Upregulation of p21 both at the transcriptional
(Fig. 2C) and translational (Fig. 2D) levels was found in
P-MEF and NIH3T3 with a wild-type p53 but not in I-MEF
and I-clones, indicating a nonfunctional p53. In keeping with
p53 functional loss all four I-clones are highly aneuploid
(hyperdiploid) (1) (Fig. 2E); furthermore, they are able to form
colonies from single cells (Fig. 2F), characteristic of immortal
cells.
We have reported that S-MEF showed upregulation of miR-
290 and in turn miR-290 overexpression induced premature
senescence in P-MEF, suggesting a potential tumor suppressor
activity of this miRNA in murine fibroblasts (9).
It was then interesting to verify whether miR-290 were
able to induce senescence in immortal clones and if this
were p53 dependent or not. To this end we used I-clones,
functionally negative for p53, as well as the immortalized
NIH3T3 cells, with wild-type p53 (1). First, we quantified
the expression of miR-290 and found that in all I-clones as
well as in NIH3T3 the expression of this miRNA is mark-
edly downregulated compared with S-MEF and significantly
downregulated compared with P-MEF (Fig. 3A). Interest-
ingly miR-290 downregulation appears to take place during
the immortalization process at the same time as p21 down-
Fig. 3. Responsiveness of I-clones to microRNA (miR)-290 transfection. A: expression level of endogenous miR-290 in S-MEF, I-clones (I-1, 2, 3, 5), and
NIH3T3 normalized to that of P-MEF; each bar represents the mean  SD of 3 biological replicates. B: heat map reporting the fold change of members of
miR-290–295 cluster in S-MEF, I-MEF, I-5, and NIH3T3 normalized to that of P-MEF (1). C: spontaneous level of senescence-associated -galactosidase
(SA--gal) cells frequency in P-MEF, S-MEF, I-clones, and NIH3T3; the mean  SD of at least 3 biological replicates are reported. D: quantification of
SA--gal cells in I-clones and NIH3T3 cells transfected with miR-290; the mean  SD of at least 3 biological replicates are reported.
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Fig. 4. Responsiveness of I-clones to nocodazole (NCZ). Cell cycle analysis of I-1 (A), I-2 (B), I-3 (C), I-5 (D), and NIH3T3 (E) cells after 16 h exposure to
NCZ; the mean  SD of at least 3 biological replicates are reported. Quantification of the expression of miR-290 (F) and members of miR-290–295 cluster (G)
and SA--gal cells induction (H) after NCZ treatment; each bar expresses the ratio between miR-290 expression (or SA--gal cell number) in NCZ-treated
cells vs. control cells. The mean  SD of at least 3 biological replicates are reported.
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regulation (11) by an unknown mechanism (genetic or
epigenetic silencing, as well as abnormal processing and
increased degradation may be responsible). In addition to
miR-290, other members of the miR-290 –295 cluster (i.e.,
miR-291–3p, miR-292–3p, and miR-295) were downregu-
lated (Fig. 3B), suggesting that either the transcription or the
processing of the entire cluster is repressed in immortal
MEF. These data also indicate that in I-MEF the miR-290 –
295 cluster is unlikely to play a prosurvival role similar to
that found in mouse embryonic stem cells, where the cluster
is overrepresented and prevents apoptosis after genotoxic
stress (17). It is worth noting that the low frequency of
SA--gal cells found in I-clones, as well as in NIH3T3
(Fig. 3C), correlates with the downregulation of miR-290, in
agreement with a potential tumor suppressor role of this
miRNA. For these reasons we asked whether overexpression
of miR-290 could activate/reactivated the senescence path-
way in these immortal clones. The results clearly indicate
that miR-290 overexpression, which increased more than
fourfold of the percentage of senescent P-MEF (9), neither
significantly addresses immortalized cells to senescence
(Fig. 3D) nor inhibits cell proliferation (data not shown).
When the intracellular concentration of miR-290 was mea-
sured a significant increase (average 500-fold) was found in
all clones, indicating that miR-290 is efficiently transfected
into cells. The poor response of NIH3T3 cells to miR-290
suggested that the presence of a functional p53 is not
sufficient to reactivate the prosenescence role of miR-290 in
immortal cells.
As NCZ, which blocks cells at the G2/M stage, is able to
increase P-MEF senescence partially by upregulating miR-290
(9), we asked whether this drug could induce senescence in
miR-290-insensitive clones. When either I-clones or NIH3T3
cells were exposed to NCZ, a significant accumulation of cells
in G2/M was observed (Fig. 4, A–E); however, contrary to
what was found in P-MEF (9), miR-290, as well as other
members of miR-290–295 cluster, did not change in I-MEF
(Fig. 4, F and G).
These data further support the hypothesis that the cell cycle
block imposed by NCZ is miR-290 independent, as previously
suggested (9). Interestingly NCZ is able to induce senescence
in NIH3T3 (4-fold), while it does not significantly induce
senescence in I-clones (Fig. 4H). Overall these data indicate
that I-clones, lacking a functional p53, are resistant to either
miR-290- or NCZ-induced senescence. Conversely NIH3T3
cells with a functional p53, although not responsive to miR-
290, are sensitive to NCZ-induced senescence. This result is
not unexpected as p53 activity plays a major role in the
spindle checkpoint, activated whenever polymerization of
spindle microtubules is affected (7). As in NIH3T3 cells,
NCZ induces senescence in the absence of miR-290 upregu-
lation, and it is evident that miR-290 is neither a sensor of
the cell cycle block nor a physiological effector of senes-
cence in these cells (9). The finding that NCZ does not
change significantly the expression of the miR-290 –295
cluster in immortal murine fibroblasts with either a nonfunc-
tional (I-MEF and I-clones) or a functional (NIH3T3) p53 is
in accordance with the hypothesis that this cluster has a
marginal role in these cells.
Overall our data indicate that miR-290 overexpression is not
able to address immortalized murine fibroblasts toward senes-
cence, even in the presence of wild-type p53 (NIH3T3); a
possible explanation is that the prosenescence targets of miR-
290 are missing in these immortal cells. As in P-MEF, miR-
290 upregulation always correlated with that of the INK4a/ARF
locus (9); we hypothesized that a likely (direct or indirect)
target of miR-290 could be a repressor of the INK4a/ARF locus
(9, 12). The high expression of p19ARF and p16 in all immor-
talized clones, suggestive of repressors loss, is in keeping with
this hypothesis. Conversely in NIH3T3 cells where the INK4a/
ARF locus is deleted (1) miR-290 becomes superfluous.
In conclusion, our data demonstrate that all selected I-MEF
clones escape senescence by functionally silencing p53 with
consequent downregulation of p21, while the INK4a/ARF lo-
cus remains expressed. Indeed, contrary to wild-type p53
NIH3T3 cells, I-clones are no longer sensitive to NCZ, a drug
that requires a functional p53 to address cells toward senes-
cence. These results are in accordance with the inactivation of
the p53 pathway being one of the commonest events in the
process of immortalization of murine fibroblasts. An interest-
ing finding of our study is that overexpression of miR-290,
markedly downregulated in I-MEF as well as in NIH3T3 cells,
is unable to enhance senescence and inhibit cell growth inde-
pendently of the p53 status. These results suggest that the
downregulation of specific miRNAs in tumor cells may be a
necessary but not sufficient prerequisite to predict their tumor
suppressor activity.
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